Highlighting Excellence in Cardiovascular Research in Canada
Submission Deadline: 31 Mar 2023
Guest Editor
Professor of Physiology and Pharmacology (retired), University of Western Ontario, London, Canada and former Canada Research Chair in Experimental Cardiology (2004-2016)
Interests: Cardiac hypertrophy; Heart failure; Cardiac myocytes; Na-H exchange; Leptin; Traditional Chinese medicines
Special Issue Information
Dear Colleagues,
We are pleased to announce the upcoming publication of a Special Issue of Reviews in Cardiovascular Medicine dedicated to highlighting excellence in cardiovascular research in Canada. Canadian researchers have an outstanding international reputation in many areas of cardiovascular research and have made important contributions to advancing our understanding and treatment of cardiovascular disorders. The goal of this Special Issue is to highlight contributions made to the field in Canadian laboratories or by Canadian investigators. Thus, the criteria for consideration for inclusion in the Special Issue is that the corresponding author should be a Canadian investigator or that the research was carried out primarily in a Canadian laboratory. Contributions may be in the form of either a Review or an Original Research article.
Topics to be covered include, but are not restricted to, the following:
Molecular and cellular mechanisms underlying myocardial remodelling and heart failure
Protection of the ischemic and reperfused myocardium
Vascular health and hypertension
Role of obesity and adipokines in cardiovascular disease
Diabetes and cardiovascular complications
Treatment of cardiovascular disease with natural products
Understanding cardiac arrhythmias
Cardiovascular pharmacology
I invite you to submit your contribution to this Special Issue of Reviews in Cardiovascular Medicine. Deadline for submission is 31 March 2023.
Prof. Dr. Morris Karmazyn
Guest Editor
Keywords
- Molecular
- Cellular mechanisms
- Myocardial remodelling
- Heart failure
- Protection
- Ischemic and reperfused myocardium
- Vascular health and hypertension
- Obesity
- Adipokines
- Cardiovascular disease
- Diabetes
- Cardiovascular complications
- Treatment
- Natural products
- Cardiac arrhythmias
Manuscript Submission Information
Manuscripts should be submitted via our online editorial system at https://imr.propub.com by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted manuscripts should be well formatted in good English.
Published Papers (6)
Status of β1-Adrenoceptor Signal Transduction System in Cardiac Hypertrophy and Heart Failure
Rev. Cardiovasc. Med. 2023, 24(9), 264; https://doi.org/10.31083/j.rcm2409264
(This article belongs to the Special Issue Highlighting Excellence in Cardiovascular Research in Canada)
The Remaining Conundrum of the Role of the Na+/H+ Exchanger Isoform 1 (NHE1) in Cardiac Physiology and Pathology: Can It Be Rectified?
Rev. Cardiovasc. Med. 2022, 23(8), 284; https://doi.org/10.31083/j.rcm2308284
(This article belongs to the Special Issue Highlighting Excellence in Cardiovascular Research in Canada)
Mechanism of Hypercholesterolemia-Induced Atherosclerosis
Rev. Cardiovasc. Med. 2022, 23(6), 212; https://doi.org/10.31083/j.rcm2306212
(This article belongs to the Special Issue Highlighting Excellence in Cardiovascular Research in Canada)
Importance of Autophagy in Mediating Cellular Responses to Iron Overload in Cardiomyocytes
Rev. Cardiovasc. Med. 2022, 23(5), 167; https://doi.org/10.31083/j.rcm2305167
(This article belongs to the Special Issue Highlighting Excellence in Cardiovascular Research in Canada)
Genetics of Normotension Preventing Hypertension Leads to a Novel Physiological Paradigm
Rev. Cardiovasc. Med. 2022, 23(4), 119; https://doi.org/10.31083/j.rcm2304119
(This article belongs to the Special Issue Highlighting Excellence in Cardiovascular Research in Canada)
Bacteria and the growing threat of multidrug resistance for invasive cardiac interventions
Rev. Cardiovasc. Med. 2022, 23(1), 15; https://doi.org/10.31083/j.rcm2301015
(This article belongs to the Special Issue Highlighting Excellence in Cardiovascular Research in Canada)